Application Information

This drug has been submitted to the FDA under the reference 022399/001.

Names and composition

"HORIZANT" is the commercial name of a drug composed of GABAPENTIN ENACARBIL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022399/001 HORIZANT GABAPENTIN ENACARBIL TABLET, EXTENDED RELEASE/ORAL 600MG
022399/002 HORIZANT GABAPENTIN ENACARBIL TABLET, EXTENDED RELEASE/ORAL 300MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022399/001 HORIZANT GABAPENTIN ENACARBIL TABLET, EXTENDED RELEASE/ORAL 600MG
022399/002 HORIZANT GABAPENTIN ENACARBIL TABLET, EXTENDED RELEASE/ORAL 300MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved